The active cases comprise 0.04 per cent of the total infections, while the national COVID-19 recovery rate was recorded as 98.74 per cent, the ministry said.
The recovery rate among COVID-19 patients was recorded at 64.53 per cent, while the fatality rate further dropped to 2.15 per cent, the data stated.
The active cases constituted 0.04 per cent of the total infections, while the national recovery rate was recorded at 98.74 per cent, the health ministry said.
The COVID-19 case fatality rate has further declined to 1.47 per cent.
This is also the highest daily rise in the last 83 days. As many as 26,624 new infections were recorded on December 20.
The number of active COVID-19 cases stands at 2,15,125, while 3,34,821 patients have been cured/discharged.
India's COVID-19 tally rose to 1,12,62,707 with 17,921 fresh cases being reported in a day, while the recoveries surpassed 1.09 crore, the Union Health Ministry said on Wednesday.
The recoveries have mounted to 11,45,629, while there are 5,67,730 active cases of coronavirus infection in the country presently.
With 19,893 new coronavirus infections being reported in a day, India's total tally of COVID-19 cases rose to 4,40,87,037, while the active cases dipped to 1,36,478, according to the Union health ministry data.
Till date eight cases of the disease have been detected in India, out of which five have foreign travel history, the minister of health and family welfare said.
The Vaccine War leans towards stoking nationalistic fervour, but that shouldn't stop you from watching a film that is solemn about the Indian scientific community's achievement, notes Mayur Sanap.
India logged 16,135 new coronavirus infections taking the total tally of COVID-19 cases to 4,35,18,564, while the active cases increased to 1,13,864, according to the Union health ministry data updated on Monday.
India saw 81,466 new coronavirus infections being reported in a span of 24 hours, the highest single-day rise in six months, taking the COVID-19 tally of cases to 1,23,03,131, according to the Union health ministry data updated on Friday.
The number of people who have recuperated from the disease surged to 98,34,141 pushing the national recovery rate to 95.99 per cent, while the COVID-19 case fatality rate stands at 1.45 per cent.
The number of people who have recuperated from the disease surged to 97,17,834, pushing the national recovery rate to 95.77 per cent, while the COVID-19 case fatality rate stands at 1.45 per cent.
India's COVID-19 caseload surpassed the somber one-crore mark Saturday, adding 10 lakh cases in nearly a month, while the total number of recoveries surged to 95.50 lakh, according to the Union health ministry data.
According to Dr V N Katoch, Director Indian Council of Medical Research (ICMR) several influenza viruses keep on circulating among human, birds and animals like pigs and keep on recombining and reasserting with each others. These changes cause genetic variations among these viruses and new viruses emerge in this process.
According to the Indian Council of Medical Research, 22,82,80,763 samples have been tested up to March 15, with 8,73,350 samples tested on Monday
The active cases now constitute 0.15 per cent of the total infections.
The total coronavirus cases mounted to 40,23,179, while the death toll climbed to 69,561 with 1,089 people succumbing to the disease in a span of 24 hours, data updated at 8 am showed.
India is currently using two vaccines for COVID-19 -- one developed by Oxford University and AstraZeneca and the other developed by Bharat Biotech in collaboration with the Indian Council of Medical Research-National Institute of Virology. Both the vaccines are being manufactured within the country by domestic firms.
With 1,209 new deaths reported across the country, the toll due to the disease stands at 76,271.
There are 8,97,394 active cases of COVID-19, which is 20.53 per cent of the total caseload in the country, the data stated.
The COVID-19 case fatality rate due to the coronavirus infection stands at 1.7 per cent.
This comes as Supreme Court is hearing a petition filed by lawyer-cum-petitioner, Gaurav Kumar Bansal, seeking an ex gratia compensation for those family members, who died due to the COVID-19 pandemic.
The national recovery rate is 93.94 per cent while the COVID-19 case fatality rate stands at 1.45 per cent.
The phase 3 trial findings indicate that Covaxin induces a robust antibody response with no severe vaccine-related adverse events or deaths reported among the trial participants, the authors of the study said.
Minister for Health and Family Welfare Anbumani Ramadoss is on an official visit to China,
India's COVID-19 tally had crossed the 20-lakh mark on August 7, 30 lakh on August 23 and 40 lakh on September 5. It went past 50 lakh on September 16, 60 lakh on September 28, 70 lakh on October 11 and crossed 80 lakh on October 29.
The COVID-19 case fatality rate has declined to 1.84 per cent.
The total cases of coronavirus infections mounted to 29,05,823, while the death toll climbed to 54,849 with 983 new fatalities being reported in a span of 24 hours, the data updated at 8 am showed.
India has been reporting over 60,000 cases daily since August 7, barring August 11 when the country registered 53,601 new instances of the infection.
This is the seventh consecutive day that COVID-19 cases have increased by more than 50,000.
A total of 25,12,388 samples have been tested for coronavirus infection as on 9 am, May 20 all over the country.
A total 16,577 infections were reported in a day, while the death toll increased to 1,56,825 with 120 new fatalities, the data updated at 8 am showed.
With this latest spike, the total cases in the country stand at 16,38,871.
The ICMR on Monday asked states and union territories to stop using the test kits procured from the Chinese companies -- Guangzhou Wondfo Biotech and Zhuhai Livzon Diagnostics -- due to "wide variations" in their performance.
The recovery rate among COVID-19 patients was recorded at 64.44 per cent, while the fatality rate was at 2.21 per cent.
Given the recurring outbreaks in the last five years, the government is considering domestic manufacturing of monoclonal antibodies for treating Nipah virus infections and is in talks with Serum Institute of India, report Shine Jacob and Sohini Das.
© 2026 Rediff.com - Investor Information - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances